Bill serves as Executive Director for Merck’s BD&L Pacific Innovation Hub which encompasses the North American West Coast and Asia Pacific. His responsibilities include structuring and negotiating partnerships with companies that offer differentiated early-stage therapeutic opportunities. Prior to joining Merck, Bill held positions in Corporate & Business Development at Jazz Pharmaceuticals and Transcept Pharmaceuticals. In addition, Bill has experience in finance and management consulting. He holds a M.B.A. from Duke University and a B.S. in engineering from the University of Pennsylvania.